At the world’s biggest AIDS meeting this week in Australia, one long-time activist and attendee sees lots of slogans and important new research findings but not nearly enough money to make use of either the potential new tools or the rallying lingo.
A new drug, Truvada, has been shown effective at preventing HIV infection and recently was endorsed by the World Health Organization for use by those most at risk of infection. Despite some disappointing news about efforts to come up with a cure for AIDS, scientists point to other research fronts, though less sexy than a cure, where progress is being made on the search for a vaccine, on treatments for preventing disease and spread of HIV.
“This is one of the most exciting times in terms of HIV science, but one of the worst of times economically,” said Mitchell Warren, executive director of AVAC (AIDS Vaccine Advocacy Coalition, which despite the name works across all aspects of disease prevention), who spoke with Humanosphere by telephone from Melbourne where the International AIDS Society is holding its biannual meeting AIDS 2014.
At the last big AIDS confab, then-Secretary of State Hillary Clinton vowed to help create an AIDS-free generation. Others spoke optimistically about the ‘end of AIDS’ as if the world is now at a tipping point, as if we are poised to end the pandemic.